ARTICLE | Clinical News
DS-1001: Ph I started
March 14, 2017 7:56 PM UTC
Daiichi began a Japanese Phase I trial to evaluate oral DS-1001 in 60 patients....
BCIQ Company Profiles
BCIQ Target Profiles
Daiichi began a Japanese Phase I trial to evaluate oral DS-1001 in 60 patients....
BCIQ Company Profiles
BCIQ Target Profiles